Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL reduced its holdings in Schrödinger, Inc. (NASDAQ:SDGR) by 9.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,575 shares of the company’s stock after selling 1,264 shares during the period. Tudor Investment Corp ET AL’s holdings in Schrödinger were worth $223,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in SDGR. Paradigm Asset Management Co. LLC acquired a new stake in Schrödinger in the 4th quarter valued at $50,000. GAMMA Investing LLC grew its position in shares of Schrödinger by 87.5% in the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company’s stock valued at $54,000 after purchasing an additional 1,305 shares during the period. KBC Group NV increased its stake in shares of Schrödinger by 73.9% during the fourth quarter. KBC Group NV now owns 4,361 shares of the company’s stock worth $84,000 after purchasing an additional 1,853 shares in the last quarter. XTX Topco Ltd acquired a new position in shares of Schrödinger during the 4th quarter worth about $199,000. Finally, Proficio Capital Partners LLC purchased a new position in Schrödinger in the 4th quarter valued at about $218,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Schrödinger Price Performance

Shares of Schrödinger stock opened at $23.90 on Friday. The stock’s 50 day simple moving average is $22.62 and its 200-day simple moving average is $21.76. The stock has a market cap of $1.75 billion, a P/E ratio of -10.21 and a beta of 1.84. Schrödinger, Inc. has a 1-year low of $16.60 and a 1-year high of $28.47.

Schrödinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company had revenue of $59.55 million during the quarter, compared to analysts’ expectations of $54.60 million. During the same quarter in the previous year, the company earned ($0.86) earnings per share. The firm’s quarterly revenue was up 62.7% compared to the same quarter last year. As a group, research analysts expect that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have commented on SDGR. Piper Sandler reduced their target price on Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. KeyCorp increased their price objective on Schrödinger from $30.00 to $32.00 and gave the company an “overweight” rating in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $32.80.

Insider Buying and Selling

In other news, insider Karen Akinsanya sold 16,723 shares of the stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $25.09, for a total value of $419,580.07. Following the completion of the sale, the insider now owns 15,625 shares of the company’s stock, valued at $392,031.25. This represents a 51.70 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $21.76, for a total transaction of $119,484.16. Following the sale, the chief financial officer now directly owns 27,544 shares in the company, valued at approximately $599,357.44. The trade was a 16.62 % decrease in their position. The disclosure for this sale can be found here. 8.60% of the stock is owned by company insiders.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.